Clin2
NCT07742644Possibly a fitNot yet recruiting

Combined MMR and chickenpox booster for children

MeaslesMumpsRubellaVaricella (Chickenpox)Measles-Mumps-Rubella+Chickenpox Vaccine

Part of Infections, Mouth & dental clinical trials.

This study tests a combined one-shot vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6 who've already had their first shots. It aims to see if this new combination vaccine is as effective and safe as giving separate boosters.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,860 people
Ages
4 years to 6 years
Study type
Interventional

Who can take part

  • Your child must be between 4 and 6 years old.
  • Your child must have had their first chickenpox and MMR (measles, mumps, rubella) shots between their 1st and 2nd birthdays.
  • Your child must have had 3 or 4 doses of the DTP (diphtheria, tetanus, whooping cough) vaccine.
  • Your child must be generally healthy — no weak immune system, chronic conditions, or nervous system disorders.
  • Your child must not have already had a second chickenpox or MMR shot.
  • Your child should not have taken immune-suppressing drugs or had certain vaccines recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07406360Recruiting· Phase 3
Combined MMR and chickenpox vaccine booster for children

This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.

Birmingham, Alabama
NCT06891872Not yet recruiting· Phase 4
Chickenpox vaccine with routine toddler shots

This study tests whether giving the chickenpox vaccine at the same time as the MMR and DTaP vaccines is safe for toddlers. Your child may get extra protection with fewer doctor visits.

Chongqing
NCT07054099Recruiting· Phase 3
Testing a chickenpox vaccine for children ages 1 to 12

This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.

Khon Kaen, Changwat Khon Kaen
NCT07473427Not yet recruiting· Phase 3
Chickenpox vaccine study for healthy children aged 1 to 12

This study tests a chickenpox (varicella) vaccine in healthy children to see how well it works and if it is safe. It may help protect your child from chickenpox.

Hanoi
NCT07415252Recruiting· Phase 3
Chickenpox vaccine study for healthy children aged 12 months to 12 years

This study tests a chickenpox vaccine in healthy children. It aims to see if a lower dose of the vaccine is as effective and safe as the standard dose. Your child may be able to join if they have never had chickenpox or the vaccine.

San Pedro Sula, Cortés Department
NCT07475000Recruiting· Phase 3
Second chickenpox vaccine for healthy children

This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.

Akdeniz

Hear when a new Measles trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.